Abstract The field of Alzheimer's disease (AD) research has seen major advances in understanding manifestations of AD‐related neuropsychiatric symptoms (NPS), including recent addition of NPS to the 2024 National Institute of Aging–Alzheimer's Association (NIA‐AA) clinical staging framework. This focused review highlig...
K. Sankhe, Daniella Vellone, Dylan X. Guan et al.· Alzheimer's & Dementia· 0 citations
Findings support the importance of optimizing care for cerebrovascular risk factors in this vulnerable population and support the importance of optimizing care for cerebrovascular risk factors in this vulnerable population.
Ethan Mah, D. Gallagher, Ye-Jin Kang et al.· Journal of Alzheimer's Disea...· 0 citations
The PACt-MD study demonstrated that combined cognitive remediation (CR) and transcranial direct current stimulation (tDCS) slows global cognitive decline in individuals with mild cognitive impairment (MCI) or remitted major depressive disorder (rMDD) over a median follow-up of four years. Prefrontal theta-gamma couplin...
Heather J. Brooks, Mina Mirjalili, Clement Ma et al.· Neuropsychopharmacology· 0 citations
BACKGROUND
Placebos have historically been used as comparative tools in randomised controlled trials (RCTs), but their therapeutic effect, particularly in psychiatric conditions, warrant a more detailed exploration to improve research design and clinical practice.
AIMS
This systematic review and meta-analysis examine...
M. Ahmadzad-Asl, Roxana Jabbarinejad, D. Shekouh et al.· The British journal of psych...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.